Skip to main content
. 2016 Mar 31;12:479–487. doi: 10.2147/TCRM.S93144

Table 4.

Medications used in acute management of hyperammonemia and their dosages

Medications Mechanism of action Dosage Route Adverse reaction*
Sodium benzoatea Conjugation with glycine to form hippuric acid Weight ≤20 kg: 250 mg/kg as loading dose over 90 minutes followed by 250–500 mg/kg/day
Weight >20 kg: 5.5 g/m2 as loading dose over 90 minutes followed by 5.5 g/m2/dayb
IV Cardiovascular: hypotension
Dermatologic: injection site reaction
Electrolytes imbalance: hyperglycemia, hypokalemia, hypernatremia
Gastrointestinal: vomiting, diarrhea
CNS: altered mental status, seizure, cerebral edema
Other: fever
Sodium phenylacetatea Conjugation with glutamine to form phenylacetylglutamine Same as for Sodium benzoate IV Same as for Sodium benzoate
AMMONUL®c Contains both sodium benzoate and sodium phenylacetate Same as for Sodium benzoate IV (AMMONUL® could be given through peripheral line on limited basis) Same as for Sodium benzoate
L-Arginine As an intermediate metabolite in the urea cycle. It can improve the flow through the urea cycle and thereby improves ammonia removal 250–400 mg/kg/day as loading dose over 90 minutes followed by 250–400 mg/kg/day IV Hyperchloremic metabolic alkalosis, hypokalemia, elevated BUN and creatinine levels, flushing, nausea, vomiting, abdominal cramps, bloating, numbness, headache
Carbaglu® (carglumic acid)d Replace N-acetylglutamate as an activator of mitochondrial carbamoyl phosphate synthetase, the first enzyme of the urea cycle 100 mg/kg bolus per NG tube, then 25–62.5 mg/kg every 6 hours NG Abdominal pain, diarrhea, vomiting, anemia, otitis media, tonsillitis, nasopharyngitis, fever, headache

Notes:

a

It should be given through central line, however, could be given peripherally on limited basis.

b

If on hemodialysis/hemodiafiltration, maintenance doses should be increased to 350 mg/kg/day (or proportional increase for body surface-based dose calculation).

c

It is supplied as a vial of 50 mL or 5,000 mg constituted of concentrated, aqueous 10% sodium benzoate and 10% sodium phenylacetate solution. Thus, each mL provides 100 mg of sodium benzoate and 100 mg of sodium phenylacetate in water. According to the prescribing information, AMMONUL must be diluted with sterile dextrose injection, 10% at ≥25 mL/kg before administration.

d

It is supplied as 200 mg tablet; 5 or 60 tablets in a polypropylene bottle with polyethylene cap and desiccant unit.

*

Generally all the drugs are well tolerated and adverse reactions are only relevant if dosages are very high.

Abbreviations: BUN, blood urea nitrogen; IV, intravenous; NG, nasogastric; CNS, central nervous system.